Personal Cfo Solutions, LLC Dbv Technologies S.A. Transaction History

Personal Cfo Solutions, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$1.15 - $3.25 $18,501 - $52,286	-16,088 Closed	0 $0
Q2 2021 Jul 22, 2021	SELL	$5.32 - $6.53 $37,240 - $45,710	-7,000 Reduced 30.32%	16,088 $88,000
Q1 2021 Apr 21, 2021	BUY	$2.75 - $6.57 $11,000 - $26,280	4,000 Added 20.96%	23,088 $123,000
Q4 2020 Feb 09, 2021	SELL	$1.38 - $3.01 $8,970 - $19,565	-6,500 Reduced 25.4%	19,088 $50,000
Q3 2020 Nov 02, 2020	SELL	$1.58 - $4.77 $3,160 - $9,540	-2,000 Reduced 7.25%	25,588 $0

Q1 2020 Apr 30, 2020	BUY	$2.33 - $12.98 $64,280 - $358,092	27,588 New	27,588 $108,000

37.7M

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $175M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of Personal Cfo Solutions, LLC, based on Form 13F filings with the SEC.

Stay updated on Personal Cfo Solutions, LLC with notifications on news.